Page 410 - Read Online
P. 410

Page 6 of 6         Almedallah et al. Neuroimmunol Neuroinflammation 2018;5:48  I  http://dx.doi.org/10.20517/2347-8659.2018.55


               neoplasm to initiate early treatment and potentially controlling this disease.


               DECLARATIONS
               Acknowledgments
               We thank Dr. Marwa Abdulkader from Department of Pathology, and Dr. Fajir Busaeed from Department
               of Radiology for providing us with the figures.

               Authors’ contributions
               Concept, literature search preparation, editing and revision of manuscript: Alsaffar G, Almedallah D, Al-
               Shabeeb G
               Patient data and imaging acquisition: Baarmah A
               Supervision and revision of manuscript: Nassim E

               Availability of data and materials
               Data available upon request.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               IRB approval from the hospital and a written informed consent were obtained.

               Consent for Publication
               Not applicable.

               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immuno-
                   logical findings and tumour association in 50 patients. Brain 2000;123:1481-94.
               2.   Lancaster E. Paraneoplastic disorders. Continuum (Minneap Minn) 2017;23:1653-79.
               3.   Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with car-cinoma. Brain 1968;91:481-96.
               4.   Bataduwaarachchi VR, Tissera N. Paraneoplastic limbic encephalitis with associated hypothalamitis mimicking a hyperdense hypotha-
                   lamic tumor: a case report. BMC Med Imaging 2016;16:8.
               5.   Asztely F, Kumlien E. The diagnosis and treatment of limbic encephalitis. Acta Neurol Scand 2012;126:365-75.
               6.   Foster AR, Caplan JP. Paraneoplastic limbic encephalitis. Psychosomatics 2009;50:108-13.
               7.   Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol
                   2016;15:391-404.
               8.   Newman MP, Blum S, Wong RC, Scott JG, Prain K, et al. Autoimmune encephalitis. In-tern Med J 2016;46:148-57.
               9.   Ducray F, Demarquay G, Graus F, Decullier E, Antoine JC, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronet-
                   work experience. Eur J Neurol 2014;21:731-5.
               10.   Ramanathan S, Mohammad SS, Brilot F, Dale RC. Autoimmune encephalitis: recent up-dates and emerging challenges. J Clin Neurosci
                   2014;21:722-30.
               11.   Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007;2:22.
   405   406   407   408   409   410   411   412   413   414   415